NCT02821351View on ClinicalTrials.gov

ACT DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

September 30, 2018

Conditions

Paroxysmal Atrial Fibrillation

Interventions

DEVICE

Radio frequency (RF) Cardiac ablation

Catheter based RF cardiac ablation to treat Paroxysmal Atrial Fibrillation

Trial Locations (4)

Unknown

St Anne's University Hospital, Brno

Institut Klinické a Experimentální Medicíny (IKEM), Prague

Nemocnice Na Homolce, Prague

Clinique Pasteur, Toulouse

All Listed Sponsors

lead

Medtronic Cardiac Ablation Solutions

INDUSTRY

NCT02821351 - ACT DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation | Biotech Hunter | Biotech Hunter